Diptheria Vaccine Market By Product (Tdap, Td, DTaP and DT) and Application (For adolescents and adults and For infants and children below 7 years) - Global Industry Analysis And Forecast To 2025
Diptheria is a major bacterial infection that affects the mucous membrane of nose and throat. Diptheria spreads easily from person to person by contact but it can be averted by using vaccines. If the is not treated then it causes serious damage to nervous system, kidneys and heart. Diptheria is caused by bacteria called Corynebacterium diphtheriae. Any person can get affected by Diptheria, by staying around an infected person, when that person sneeze, coughs or blows nose. Corynebacterium diphtheria mainly affects nose and throat, after that the bacteria releases dangerous substances (toxins), which spread through bloodstream. Diptheria Vaccine use is increasing due to increase in awareness among people and environmental conditions that are favorable for the growth of this bacteria. Therefore, the Diptheria Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global Diptheria Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
The global Diptheria Vaccine Market is based on segment, by Product the market is segmented into Tdap, Td, DTaP and DT; and by Application the market is segmented into for adolescents and adults and For infants and children below 7 years.
Diptheria Vaccine Market, By Product
Diptheria Vaccine Market, By Application
For adolescents and adults
For infants and children below 7 years
On a global front, the Diptheria Vaccine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).
Diptheria Vaccine Market, By Region
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
The leading players in the market are Novartis, Wuhan Institute of Biological Products, Sanofi Pasteur, Chengdu Institute of Biological Products, Merck, Changchun Changsheng Life Sciences, Wyeth Pfizer, Beijing Tiantan Biological Products, Shanghai Institute of Biological Products and GlaxoSmithKline. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
Wuhan Institute of Biological Products
Chengdu Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Shanghai Institute of Biological Products
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?